Therapeutic archive
ISSN 0040-3660 (Print)
ISSN 2309-5342 (Online)
Menu
Archives
Home
About the Journal
Editorial Team
Editorial Policies
Author Guidelines
About the Journal
Issues
Search
Current
Archives
Contact
Editorial Board
All Journals
User
Username
Password
Remember me
Forgot password?
Register
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
By Sections
Other Journals
×
User
Username
Password
Remember me
Forgot password?
Register
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
By Sections
Other Journals
Home
>
Search
>
Author Details
Author Details
Kagramanova, A V
Issue
Section
Title
File
Vol 84, No 2 (2012)
Editorial
Impairment of intestinal mucosa composition in mechanisms of intestinal dysfunction development in patients with hepatic cirrhosis
Vol 88, No 2 (2016)
Editorial
Current principles in the screening, diagnosis, and therapy of colorectal cancer
(Rus)
Vol 88, No 8 (2016)
Editorial
Long-term infliximab therapy for ulcerative colitis in real clinical practice
(Rus)
Vol 89, No 2 (2017)
Editorial
Efficacy of adalimumab for Crohn’s disease in real clinical practice
(Rus)
Vol 90, No 3 (2018)
Editorial
Stem Cell Therapy for Perianal Crohn’s Disease
(Rus)
Vol 90, No 6 (2018)
Editorial
Efficacy and tolerability of certolizumab pegol in Crohn's disease in clinical practice
(Rus)
Vol 90, No 2 (2018)
Editorial
Personalized medicine in the treatment of inflammatory bowel diseases
(Rus)
Vol 90, No 2 (2018)
Editorial
Mesenchymal stromal cells of bone marrow and azathioprine in Crohn's disease therapy
(Rus)
Vol 90, No 12 (2018)
Editorial
Adherence to therapy of patients with inflammatory bowel diseases
(Rus)
Vol 90, No 11 (2018)
Editorial
Clostridium difficile in inflammatory bowel disease
(Rus)
Vol 91, No 4 (2019)
Editorial
O.V. Knyazev, A.V. Kagramanova, I.A. Korneeva, K.K. Noskova, S.V. Belousov, A.I. Parfenov
(Rus)
Vol 91, No 8 (2019)
Editorial
Evaluation of efficacy and comparative frequency of adverse events in patients with ulcerative colitis receiving the original infliximab and its biosimilar. One year of observation
(Rus)
This website uses cookies
You consent to our cookies if you continue to use our website.
About Cookies
TOP